» Articles » PMID: 34858167

Navigating Calcium and Reactive Oxygen Species by Natural Flavones for the Treatment of Heart Failure

Overview
Journal Front Pharmacol
Date 2021 Dec 3
PMID 34858167
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Heart failure (HF), the leading cause of death among men and women world-wide, causes great health and economic burdens. HF can be triggered by many factors, such as coronary artery disease, heart attack, cardiomyopathy, hypertension, obesity, etc., all of which have close relations with calcium signal and the level of reactive oxygen species (ROS). Calcium is an essential second messenger in signaling pathways, playing a pivotal role in regulating the life and death of cardiomyocytes via the calcium-apoptosis link mediated by the cellular level of calcium. Meanwhile, calcium can also control the rate of energy production in mitochondria that are the major resources of ROS whose overproduction can lead to cell death. More importantly, there are bidirectional interactions between calcium and ROS, and such interactions may have therapeutic implications in treating HF through finely tuning the balance between these two by certain drugs. Many naturally derived products, e.g., flavones and isoflavones, have been shown to possess activities in regulating calcium and ROS simultaneously, thereby leading to a balanced microenvironment in heart tissues to exert therapeutic efficacies in HF. In this mini review, we aimed to provide an updated knowledge of the interplay between calcium and ROS in the development of HF. In addition, we summarized the recent studies (, and in clinical trials) using natural isolated flavones and isoflavones in treating HF. Critical challenges are also discussed. The information collected may help to evoke multidisciplinary efforts in developing novel agents for the potential prevention and treatment of HF.

Citing Articles

Naturally occurring small molecules with dual effect upon inflammatory signaling pathways and endoplasmic reticulum stress response.

da Silva D, Valentao P, Pereira D J Physiol Biochem. 2024; 80(2):421-437.

PMID: 38502466 PMC: 11074028. DOI: 10.1007/s13105-024-01014-1.


Editorial: Novel Small-Molecule Agents in Overcoming Multidrug Resistance in Cancers.

Cui Q, Wang C, Zeng L, Zhou Q, Fan Y Front Chem. 2022; 10:921985.

PMID: 35601552 PMC: 9114663. DOI: 10.3389/fchem.2022.921985.


A Mini-Review of Flavone Isomers Apigenin and Genistein in Prostate Cancer Treatment.

Ji X, Liu K, Li Q, Shen Q, Han F, Ye Q Front Pharmacol. 2022; 13:851589.

PMID: 35359832 PMC: 8962830. DOI: 10.3389/fphar.2022.851589.

References
1.
Li F, Lang F, Zhang H, Xu L, Wang Y, Zhai C . Apigenin Alleviates Endotoxin-Induced Myocardial Toxicity by Modulating Inflammation, Oxidative Stress, and Autophagy. Oxid Med Cell Longev. 2017; 2017:2302896. PMC: 5554558. DOI: 10.1155/2017/2302896. View

2.
Landstrom A, Dobrev D, Wehrens X . Calcium Signaling and Cardiac Arrhythmias. Circ Res. 2017; 120(12):1969-1993. PMC: 5607780. DOI: 10.1161/CIRCRESAHA.117.310083. View

3.
Weintraub N, Collins S, Pang P, Levy P, Anderson A, Arslanian-Engoren C . Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation. 2010; 122(19):1975-96. DOI: 10.1161/CIR.0b013e3181f9a223. View

4.
Zhao F, Fu L, Yang W, Dong Y, Yang J, Sun S . Cardioprotective effects of baicalein on heart failure via modulation of Ca(2+) handling proteins in vivo and in vitro. Life Sci. 2015; 145:213-23. DOI: 10.1016/j.lfs.2015.12.036. View

5.
Matori H, Umar S, Nadadur R, Sharma S, Partow-Navid R, Afkhami M . Genistein, a soy phytoestrogen, reverses severe pulmonary hypertension and prevents right heart failure in rats. Hypertension. 2012; 60(2):425-30. PMC: 4252152. DOI: 10.1161/HYPERTENSIONAHA.112.191445. View